Clinical trial
Study on the Efficacy of Alprostadil Injection in Patients With Acute Ischemic Stroke
NCT03252626 is registered in ClinicalTrials.gov with The First Hospital of Jilin University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study on the Efficacy of Alprostadil Injection in Patients With Acute Ischemic Stroke
- Lead sponsor
- The First Hospital of Jilin University
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- April 18, 2024
- Completion date
- June 30, 2025
- Enrollment
- 950 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.